EPIZYME INC (EPZM)
US29428V1044 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to EPZM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.04. This target is 107% above the current price.
EPZM was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about EPZM.
In the previous month the buy percentage consensus was at a similar level.
EPZM was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-06-28 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2022-06-27 | Wedbush | Downgrade | Outperform -> Neutral |
| 2022-06-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-12 | HC Wainwright & Co. | Maintains | Buy |
| 2022-03-02 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-10 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2021-08-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-07 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-05-07 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-04-19 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-03-31 | Credit Suisse | Initiate | Outperform |
| 2021-02-25 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |